1 / 8

OUR FOCUS : UN POLITICAL DECLARATION TARGET No. 4

OUR FOCUS : UN POLITICAL DECLARATION TARGET No. 4. 54% of all people eligible were receiving antiretroviral therapy in low- and middle-income countries in 2011. Legend. Number of people eligible for antiretroviral therapy. . Percentage receiving ART in 2011. Source: UNAIDS, 2012.

booth
Download Presentation

OUR FOCUS : UN POLITICAL DECLARATION TARGET No. 4

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. OUR FOCUS: UN POLITICAL DECLARATION TARGET No. 4

  2. 54% of all people eligible were receiving antiretroviral therapy in low- and middle-income countries in 2011 Legend Number of people eligiblefor antiretroviral therapy. Percentage receiving ART in 2011. Source: UNAIDS, 2012

  3. Return for investment Likelihood of employment before and after starting antiretroviral therapy KwaZulu-Natal, South Africa Before treatment After starting treatment Sources: Bärnighausen T et al, The economic benefits of ART: evidence from a complete population cohort in rural South Africa 2nd International HIV Workshop on Treatment as Prevention, Vancouver, Canada, April 2012.

  4. Percentage of people retained in treatment and care after diagnosis, USA and Mozambique 100% USA Mozambique Retained in treatment and care 0 Diagnosedwith HIV Eligiblefor ART InitiatedART Adherentor undetectable Linked/enrolled in care Tested <30 days Retained in care Source: Gardner E M et al. Clin Infect Dis. 2011;52:793-800; Micek et al JAIDS 2009

  5. Percentage of people retained in treatment and care after diagnosis, USA and Mozambique • To improve testing: • Reduce stigma in the community and in healthcare settings • Strengthen community support and referral networks • Enhance human rights literacy 100% USA Mozambique Retained in treatment and care 0 Diagnosedwith HIV Eligiblefor ART InitiatedART Adherentor undetectable Linked/enrolled in care Tested <30 days Retained in care Source: Gardner E M et al. Clin Infect Dis. 2011;52:793-800; Micek et al JAIDS 2009

  6. Percentage of people retained in treatment and care after diagnosis, USA and Mozambique • Improve enrolment in care: • Expand community-centred delivery • Overcome cost & transport barriers • Enhance treatment & rights literacy 100% USA Mozambique Retained in treatment and care 0 Diagnosedwith HIV Eligiblefor ART InitiatedART Adherentor undetectable Linked/enrolled in care Tested <30 days Retained in care Source: Gardner E M et al. Clin Infect Dis. 2011;52:793-800; Micek et al JAIDS 2009

  7. Percentage of people retained in treatment and care after diagnosis, USA and Mozambique • Get more people on treatment: • Enhance peer support programmes • Reduce costs • Overcome transport barriers • Ensure adequate nutrition • Reduce stigma in healthcare settings 100% USA Mozambique Retained in treatment and care 0 Diagnosedwith HIV Eligiblefor ART InitiatedART Adherentor undetectable Linked/enrolled in care Tested <30 days Retained in care Source: Gardner E M et al. Clin Infect Dis. 2011;52:793-800; Micek et al JAIDS 2009

  8. Percentage of people retained in treatment and care after diagnosis, USA and Mozambique • Retain people on treatment: • Adherence support programmes • Reduce gender inequalities • Reduce fear of disclosure • Overcome cost and transport barriers • Referral and support programmes for migrants 100% USA Mozambique Retained in treatment and care 0 Diagnosedwith HIV Eligiblefor ART InitiatedART Adherentor undetectable Linked/enrolled in care Tested <30 days Retained in care Source: Gardner E M et al. Clin Infect Dis. 2011;52:793-800; Micek et al JAIDS 2009

More Related